Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN053
hosted by Dr. Jill Knerath · StayCurrentMD
Part of
Wilms Tumor 20 items
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Updated Favorable histology Wilms tumor risk stratification: Rationale for future Children’s Oncology Group clinical trials
53 s · Published Apr 2026
Video
Wilms Tumor Protocol Violations: 2018 Pediatric Surgery Practice Gap #3
Dr. Todd Ponsky · Published Jun 2019
Video
Wilms Tumor Protocol Violations: Practice Gap discussion at Update Course 2018
9 min · Published Aug 2018
Video
Wilms Tumor Rapid Fire: Update Course 2015
8 min · Published Nov 2015
Video
Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and Hepatoblastoma
1 min · Published Jan 2026
Video
Compiled Sandler Rapid Fire Sessions: Update Course 2015
29 min · Published Nov 2015
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
What the experts said
Dick et al. published a report from a Children's Oncology Group study in the Journal of Clinical Oncology in 2025
The study examined factors in patients with favorable histology Wilms tumor and pulmonary metastases and how those factors may affect outcomes
Factors studied included the number of metastases, the size of the metastases, and different biological markers
There was no difference in survival based on the number of metastases
Patients who had a rapid response to chemotherapy with larger nodules showed worse event-free survival
Patients with larger nodules and rapid response to chemotherapy showed no changes in overall survival
In multivariable models, neither the size nor the number of nodules had any effect on survival
1q gain was associated with worse event-free survival
1q gain was associated with worse overall survival
1q gain is the superior prognostic factor when compared to size and number of nodules in patients with favorable histology Wilms tumor and pulmonary metastases